Institute for Digital Medicine
Fraunhofer Institute for Digital Medicine MEVIS
The mission of Fraunhofer MEVIS is to advance health care by researching and bringing to market solutions for computer-aided medicine, bridging between medical imaging, image-guided therapy, and healthcare informatics. Our focus is to make an impact in clinical routine use. We work closely with clinical and industrial partners to ensure the relevance of our work, to select research topics based on the expected impact on medical care, and to translate our R&D results into viable innovations.
We strive to improve accuracy, safety, and efficiency of diagnostic and therapeutic procedures by utilizing our medical computing competences: image acquisition, reconstruction, processing, and quantitative analysis; mathematical modeling and simulation; machine learning, deep learning, and artificial intelligence in medicine; as well as human-computer-interaction and user experience engineering. Our strengths are rapid prototyping of software applications, modular software development, and efficient ISO-certified quality assurance. We position ourselves as a prime partner for research and development in the area of computer-assisted medicine as well as for translation of research results into medical products.
MEVIS was founded in August 1995 in Bremen as MeVis Research gGmbH and has been an institute of the Fraunhofer Society since January 2009, named Fraunhofer Institute for Medical Image Computing until the end of 2018. We are based in Bremen, Lübeck, Berlin, and Aachen.
Research and Development for Digital Medicine, Development of Clinical Software, Quality-Assured Software Components for Medical Products, Image & Data Analysis, Quantitative Pathology, Image Registration, Modeling & Simulation, and Imaging Physics
Fraunhofer MEVIS develops real-world medical software solutions for image-supported early detection, diagnosis, and therapy. Strong focus is placed on cancer as well as diseases of the circulatory system, brain, breast, liver, and lung. The goal is to detect diseases earlier and more reliably, tailor treatments to each individual, and make therapeutic success more measurable.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
SPIE, the international society for optics and photonics Research, Non-profit Organizations | SPIE, the international society for optics and photonics Research, Non-profit Organizations | Other 28 Feb 2023 | | |
European Space Agency - ESA Defence and Aerospace, Aviation and Aerospace Component Manufacturing | European Space Agency - ESA Defence and Aerospace, Aviation and Aerospace Component Manufacturing | Capitalistic Partnership Event 26 Sep 2017 | | |
Research in Germany Research, Startup accelerator & VC, Research Services | Research in Germany Research, Startup accelerator & VC, Research Services | Other 12 Nov 2021 | | |
Fraunhofer-Gesellschaft Research, Research Services | Fraunhofer-Gesellschaft Research, Research Services | Other 29 Jun 2022 | | |
Deutsches Forschungszentrum für Künstliche Intelligenz (DFKI) Research, Research Services | Deutsches Forschungszentrum für Künstliche Intelligenz (DFKI) Research, Research Services | Not capitalistic Partnership Not event 19 Jun 2023 13 Feb 2024 | | |